Reports from Ossian Health Economics and Communications GmbH Advance Knowledge in Antidiabetic Agents (Early use of oral semaglutide in the UK: A cost-effectiveness analysis versus continuing metformin and SGLT-2 inhibitor therapy).

Keywords: Antidiabetic Agents; Biguanides; Business; Drugs and Therapies; GLP-1 Receptor Agonist; Health and Medicine; Hypoglycemic Agents; Metformin; Metformin Therapy; Non-Sulfonylureas; Peptide Hormones; Peptide Proteins; Pharmaceuticals; Proinsulin EN Antidiabetic Agents Biguanides Business Drugs and Therapies GLP-1 Receptor Agonist Health and Medicine Hypoglycemic Agents Metformin Metformin Therapy Non-Sulfonylureas Peptide Hormones Peptide Proteins Pharmaceuticals Proinsulin 261 261 1 10/16/23 20231017 NES 231017 2023 OCT 16 (NewsRx) -- By a News Reporter-Staff News Editor at Diabetes Week -- A new study on antidiabetic agents is now available. Antidiabetic Agents, Biguanides, Business, Drugs and Therapies, GLP-1 Receptor Agonist, Health and Medicine, Hypoglycemic Agents, Metformin, Metformin Therapy, Non-Sulfonylureas, Peptide Hormones, Peptide Proteins, Pharmaceuticals, Proinsulin. [Extracted from the article]